Licenses
Phylonix has a number of issued and pending patent applications in the US and other territories which may be available for licensing.
For non commercial, academic research use, royalty free licenses are available. For commercial use for both non profit (sponsored research or translational medicine programs) and profit entities, annual license fees are required. For further information, fill out our contact form.
Drug Screening in Multi-well plates, Patent Number: EP 1878 799 B1
Abstract: This invention describes methods for screening agents using multi-well plates and automated methods. The invention also describes assessing compound effects on toxicity, cell death and angiogenesis.
Drug effects on Angiogenesis, Patent Number: EP 1066 402 B1
Abstract: This invention describes methods for assessing drug effects on angiogenesis.
Xenotransplant, Patent Number: EP 1826 560 B1
Abstract: This invention describes xenotransplant models for drug screening.
Compound Effects on CNS, Patent Number: 7,951,989
Abstract: This invention describes methods for assessing compound effects on central nervous system.
Drug effects on eyes, Patent Number: 7,897,363
Abstract: This invention describes methods for screening compound effects on zebrafish eyes.
Xenotransplant, Patent Number: 7,838,726
Abstract: This invention describes methods for assessing drug effects on transplanted human cells.
Brain and Central Nervous System, Patent Number: 7,767,880
Abstract: This invention describes methods for assessing compound effects on central nervous system and determining blood brain barrier permeability.
Compound Induced Changes in mRNA or proteins, Patent Number: 7,687,682
Abstract: This invention described methods for detecting compound induced changes in mRNA or proteins, including use of arrays.
Cardiac Function, Patent Number: 7,482,507
Abstract: This invention describes methods for assessing drug effects on cardiac functions including heart rate and contractility.
Changes in mRNA and Proteins, Patent Number: 7,435,870
Abstract: This invention describes methods for assessing compound induced changes in mRNAs and proteins.
Xenotransplant, Patent Number: 7,408,095
Abstract: This invention describes methods for assessing if transplanted cells are cancer cells or pathogens.
Angiogenesis, Patent Number: 7,041,276
Abstract: This invention describes methods for screening an agent for effects on angiogenesis.
Xenotransplant, Patent Number: 6,761,876
Abstract: This invention describes methods for introducing heterologous cells into zebrafish and screening drug effects.
Multi-Well Plates, Patent Number: 6,656,449
Abstract: This invention describes methods of screening an agent for activity using multi-well plates and automated methods.
Cell Death, Patent Number: 6,299,858
Abstract: This invention provides describes methods for screening an agent for toxic activity and inducing cell death.
Pending
Claims for assessing organ specific toxicity, identifying novel drug targets, as well as continuations and divisionals of issued patents are pending in territories around the world.
<<Back to Home Page
Contact Us
Please contact us with any questions about our service offerings, licensing opportunities, partnerships, and general inquiries.
Contact Form